Immunogen reported $43.44M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 10036M 518M
Acceleron Pharma XLRN:US $ 104.83M 13.23M
Agios Pharmaceuticals AGIO:US $ 89.16M 66K
Amgen AMGN:US $ 4.33B 1.37B
Arena Pharmaceuticals ARNA:US $ 194.48M 50.09M
Astellas Pharma 4503:JP 271.44B 18.61B
AstraZeneca AZN:LN 11.54B 4.45B
Bluebird Bio BLUE:US $ 239.63M 8.68M
Bristol Myers Squibb BMY:US $ 9.63B 360M
Cerulean Pharma CERU:US $ 12.67M 3.51M
Dicerna Pharmaceuticals DRNA:US $ 83.23M 1.64M
Eli Lilly And LLY:US $ 5296.8M 39.9M
Emergent Biosolutions EBS:US $ 363.7M 19.3M
Exelixis EXEL:US $ 276.8M 14.63M
Halozyme Therapeutics HALO:US $ 40.24M 3.16M
Heron Therapeutics HRTX:US $ 74.94M 7.97M
Immunogen IMGN:US $ 43.44M 873K
Intrexon XON:US $ 47.03M 2.22M
Karyopharm Therapeutics KPTI:US $ 81.5M 9.85M
Macrogenics MGNX:US $ 68.65M 2.39M
Nektar Therapeutics NKTR:US $ 138.52M 18K
Novartis NVS:US 10.13B 319M
Pfizer PFE:US $ 16447M 3384M
Regeneron Pharmaceuticals REGN:US $ 1605.6M 185.7M
Seattle Genetics SGEN:US $ 722.02M 243.94M